⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ELVN News
Enliven Therapeutics, Inc. Common Stock
Enliven Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
prnewswire.com
ELVN
Form 8-K
sec.gov
ELVN
Form 8-K
sec.gov
ELVN
Enliven Therapeutics to Present at Upcoming Investor Conferences
prnewswire.com
ELVN
Enliven Therapeutics Announces Oral Presentation at the EHA 2026 Congress Featuring Additional Positive Phase 1 Clinical Trial Data for ELVN-001 in CML
prnewswire.com
ELVN
Form 8-K
sec.gov
ELVN
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update
prnewswire.com
ELVN
Form 8-K
sec.gov
ELVN
Enliven Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
prnewswire.com
ELVN
Enliven Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
prnewswire.com
ELVN